Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Carolus Therapeutics Inc.

www.carolustherapeutics.com

Latest From Carolus Therapeutics Inc.

Carolus Therapeutics Inc.

Macrophage migration inhibiting factor (MIF) has been a target for drug developers for years because of its potential to fight inflammation in a variety of indications. To date, efforts targeting MIF have been largely unsuccessful perhaps because, as Carolus Therapeutics' scientific founders theorized, MIF activity is mediated through two chemokine receptors, CXCR2 and CXCR4. Carolus has developed peptides that selectively disrupt MIF binding to those receptors, It also has a therapeutic antibodies program for MIF. If successful, its compunds could find application in a range of diseases, including cardiovascular disease, tissue transplant rejection, cancer, and a number of orphan indications
BioPharmaceutical

Start-Up Previews (05/2009)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Medical Dermatology Gets Under VCs' Skin," features profiles of Garnet Biotherapeutics, Medimetriks and Topica Pharmaceuticals. Plus these Start-Ups Across Health Care: Carolus Therapeutics, Forma Therapeutics, NovaLign Orthopaedics, OmegaGenesis and PercSys.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Carolus Therapeutics Inc.
  • Senior Management
  • Court Turner, CEO
    Douglas Downs, CFO
    Joshua R Schultz, PhD, VP, Res.
  • Contact Info
  • Carolus Therapeutics Inc.
    Phone: (858) 768-7823
    5626 Oberlin Dr.
    Ste. 100
    San Diego, CA 92121
    USA
UsernamePublicRestriction

Register